Mitronite

Natural health product licensed in Canada

Licence holder

Mitronite Inc.

NPN or DIN-HM

80070757

Status

Active licence

Licence date

29 June 2016

Revision date

Not provided

Form

Capsule

Route of administration

Orale

Application type

Officinale

If this product were sold in France

• Dose déclarée au-delà d'une limite

  Calcium: up to 864 mg a day according to the dosing instructions published by Health Canada (12 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• Dose déclarée au-delà d'une limite

  Vitamine C: up to 1,200 mg a day according to the dosing instructions published by Health Canada (12 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Acide L-malique, Hypromellose

Recommended doses in Canada

Uses authorised in Canada

Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Source of/An electrolyte for the maintenance of good health. Helps to maintain normal muscle function. Helps in the process of normal regulation of cell division and specialisation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in wound healing. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to maintain immune function. Helps to maintain the body's ability to metabolize nutrients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80070757

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.